Valuation: Tellgen Corporation

Market Cap 1.94B 287M 251M 232M 214M 403M 27.64B 409M 2.78B 1.09B 13.52B 1.08B 1.05B 46.59B P/E 2024
66.3x
P/E 2025 836x
Enterprise Value 1.73B 256M 224M 207M 190M 359M 24.64B 365M 2.48B 970M 12.06B 960M 939M 41.54B EV / Sales 2024
4.21x
EV / Sales 2025 7.5x
Free-Float
66.27%
Yield 2024
1.06%
Yield 2025 0.54%
1 day-3.50%
1 week-3.27%
Current month+2.88%
1 month-3.42%
3 months-27.87%
6 months-39.33%
Current year-33.99%
1 week 11.99
Extreme 11.99
13.77
1 month 11.4
Extreme 11.4
13.77
Current year 11.4
Extreme 11.4
22.87
1 year 11.4
Extreme 11.4
32.8
3 years 9.94
Extreme 9.94
32.8
5 years 9.94
Extreme 9.94
43.66
10 years 9.94
Extreme 9.94
50.25
Manager TitleAgeSince
Chief Executive Officer 56 05/11/2003
Director of Finance/CFO 50 08/06/2023
Chief Tech/Sci/R&D Officer 45 08/12/2020
Director TitleAgeSince
Chairman 56 05/11/2003
Director/Board Member 44 08/12/2020
Director/Board Member 47 08/12/2020
Change 5-day change 1-year change 3-year change Capi.($)
-3.50%-3.27%-25.93%-38.28% 297M
-5.00%-5.04%+229.56%+303.14% 20.67B
-1.10%+3.44%-39.02%-23.29% 9.85B
-2.96%+1.15%+48.97%+25.52% 7B
-1.19%+3.84%+275.87%-25.85% 5.55B
+3.43%+7.18%-14.36%-20.83% 5.23B
-8.46%+23.30%+84.85%+105.62% 4.9B
-5.64%-6.04%-43.34% - 4.66B
+1.27%+2.01%-22.43%-25.26% 4.2B
+1.21%+5.98%-14.81%-39.11% 2.72B
Average -1.54%+2.30%+47.94%+29.07% 6.51B
Weighted average by Cap. -1.89%+1.00%+95.73%+103.52%

Financials

2024 2025
Net sales 437M 64.5M 56.54M 52.26M 48.06M 90.69M 6.22B 92.14M 625M 245M 3.04B 242M 237M 10.49B 364M 53.73M 47.09M 43.53M 40.04M 75.54M 5.18B 76.75M 521M 204M 2.54B 202M 197M 8.73B
Net income 34.53M 5.1M 4.47M 4.13M 3.8M 7.17M 492M 7.29M 49.41M 19.37M 241M 19.15M 18.73M 829M 3.59M 530K 464K 429K 395K 745K 51.09M 757K 5.13M 2.01M 25M 1.99M 1.95M 86.13M
Net Debt -434M -64.13M -56.21M -51.95M -47.78M -90.16M -6.18B -91.61M -621M -244M -3.03B -241M -236M -10.42B -210M -31.06M -27.23M -25.17M -23.15M -43.67M -3B -44.37M -301M -118M -1.47B -117M -114M -5.05B
Logo Tellgen Corporation
Tellgen Corp is a China-based company primarily engaged in the research and development, production and sales of in vitro diagnostic products. The Company's products mainly cover the fields of immunity, molecules and biochemistry, involving autoimmunity, tumors, cardiovascular, infection, hormones, metabolism and other fields. The Company's main products include tumor marker detection products, human papillomavirus (HPV) nucleic acid detection products, autoimmune disease detection products, methylation mutation detection products and other products. The Company conducts its business in the domestic and overseas markets.
Employees
683
Date Price Change Volume
19/07/26 CN¥12.14 -3.50% 5,066,600
17/07/26 CN¥12.58 -7.50% 5,415,560
16/07/26 CN¥13.60 +1.72% 7,309,260
15/07/26 CN¥13.37 +6.62% 7,219,702
14/07/26 CN¥12.54 +2.62% 3,628,500

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300642 Stock